🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/05/1990 | 11,75 | 11,75 | 11,67 | 11,71 | +0,17% | 0,68% | 2.643.475 |
| 03/05/1990 | 11,73 | 11,75 | 11,65 | 11,69 | -0,17% | 0,85% | 2.686.234 |
| 02/05/1990 | 11,61 | 11,71 | 11,59 | 11,71 | +0,51% | 1,03% | 3.575.986 |
| 01/05/1990 | 11,75 | 11,77 | 11,57 | 11,65 | +0,00% | 1,69% | 2.705.098 |
| 30/04/1990 | 11,47 | 11,67 | 11,39 | 11,65 | +1,38% | 2,43% | 3.854.544 |
| 27/04/1990 | 11,61 | 11,65 | 11,47 | 11,49 | -1,37% | 1,54% | 2.762.947 |
| 26/04/1990 | 11,63 | 11,69 | 11,51 | 11,65 | +1,03% | 1,54% | 3.250.896 |
| 25/04/1990 | 11,53 | 11,61 | 11,51 | 11,53 | +0,35% | 0,86% | 2.976.739 |
| 24/04/1990 | 11,69 | 11,69 | 11,49 | 11,49 | -1,53% | 1,70% | 3.825.619 |
| 23/04/1990 | 11,73 | 11,75 | 11,63 | 11,67 | -1,34% | 1,02% | 4.234.968 |
| 20/04/1990 | 11,79 | 11,85 | 11,65 | 11,83 | -0,33% | 1,69% | 7.278.360 |
| 19/04/1990 | 11,79 | 11,95 | 11,77 | 11,87 | +0,34% | 1,52% | 4.824.782 |
| 18/04/1990 | 11,85 | 11,91 | 11,79 | 11,83 | +0,85% | 1,01% | 6.752.683 |
| 17/04/1990 | 11,65 | 11,75 | 11,59 | 11,73 | -0,34% | 1,37% | 3.008.808 |
| 16/04/1990 | 11,91 | 11,93 | 11,75 | 11,77 | -1,00% | 1,50% | 2.798.789 |
| 12/04/1990 | 11,77 | 11,89 | 11,75 | 11,89 | +1,18% | 1,18% | 3.347.731 |
| 11/04/1990 | 11,79 | 11,85 | 11,71 | 11,75 | +0,17% | 1,18% | 3.702.374 |
| 10/04/1990 | 11,63 | 11,77 | 11,57 | 11,73 | +0,51% | 1,71% | 2.754.773 |
| 09/04/1990 | 11,47 | 11,69 | 11,47 | 11,67 | +0,86% | 1,91% | 3.001.891 |
| 06/04/1990 | 11,55 | 11,59 | 11,43 | 11,57 | +0,87% | 1,38% | 2.339.765 |
| 05/04/1990 | 11,37 | 11,57 | 11,35 | 11,47 | +1,23% | 1,92% | 4.050.730 |
| 04/04/1990 | 11,41 | 11,51 | 11,29 | 11,33 | -0,52% | 1,92% | 4.336.834 |
| 03/04/1990 | 11,23 | 11,45 | 11,19 | 11,39 | +1,78% | 2,30% | 4.658.779 |
| 02/04/1990 | 10,97 | 11,19 | 10,93 | 11,19 | +1,26% | 2,36% | 4.202.899 |
| 30/03/1990 | 11,29 | 11,29 | 11,05 | 11,05 | -2,11% | 2,11% | 3.477.264 |
| 29/03/1990 | 11,43 | 11,51 | 11,25 | 11,29 | -1,22% | 2,26% | 4.818.494 |
| 28/03/1990 | 11,31 | 11,45 | 11,29 | 11,43 | +0,70% | 1,41% | 4.050.730 |
| 27/03/1990 | 11,09 | 11,37 | 11,03 | 11,35 | +2,33% | 3,05% | 3.735.701 |
| 26/03/1990 | 11,13 | 11,21 | 11,09 | 11,09 | +0,18% | 1,07% | 2.172.504 |
| 23/03/1990 | 10,95 | 11,09 | 10,95 | 11,07 | +1,27% | 1,27% | 2.649.763 |